Xiaomei LU

Dr. Xiaomei LU


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Molecular Biomedicine
Verified
Journal Article
Open access
PDF file
Shutao ZhengShutao Zheng
Shutao Zheng
SHShuo He
Shuo He
YLYan Liang
Yan Liang
YTYiyi Tan
Yiyi Tan
QLQing Liu
Qing Liu
XLXiaomei LU
Xiaomei LU
Compared with those in adenocarcinoma, PIK3CA mutations are more common in squamous cell carcinoma (SCC), which arises from stratified squamous epithelia that are usually exposed to adverse environmental factors. Although hotspot mutations in exons 9 and 20 of PIK3CA, including E542K, E545K, H1047L and H1047R, are frequently encountered in the clinic, their clinicopathological meaning remains to be determined in the context of SCC. Considering that few reviews on PIK3CA mutations in SCC are available in the literature, we undertook this review to shed light on the clinical significance of PIK3CA mutations, mainly regarding the implications and ramifications of PIK3CA mutations in malignant cell behavior, prognosis, relapse or recurrence and chemo- or radioresistance of SCC. It should be noted that only those studies regarding SCC in which PIK3CA was mutated were cherry-picked, which fell within the scope of this review. However, the role of mutated PIK3CA in adenocarcinoma has not been discussed. In addition, mutations occurring in other main members of the PI3K-AKT-mTOR signaling pathway other than PIK3CA were also excluded.

18 May 2026 in Apoptosis
Verified
Journal Article
Closed access
SLShujuan Luo
Shujuan Luo
ANAididar Nurbahati
Aididar Nurbahati
BCBangwu Cai
Bangwu Cai
HCHong Cui
Hong Cui
TPTianyuan Peng
Tianyuan Peng
Shutao ZhengShutao Zheng
Shutao Zheng

18 June 2024 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
YLYan Liang
Yan Liang
SHShuo He
Shuo He
QLQing Liu
Qing Liu
TLTao Liu
Tao Liu
YTYiyi Tan
Yiyi Tan
Shutao ZhengShutao Zheng
Shutao Zheng

30 May 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
YWYuting Wang
Yuting Wang
JYJicheng Yue
Jicheng Yue
MXMingzhe Xiao
Mingzhe Xiao
XLXiaomei LU
Xiaomei LU
YCY.Eugene Chin
Y.Eugene Chin
Axin1 is a fundamental scaffolding protein of the destruction complex in the canonical Wnt signaling pathway, which plays a critical role in various biological processes. However, how Axin1 is regulated in the activation of the canonical Wnt signaling pathway remains elusive. Here, we report that Axin1 is constitutively acetylated in resting cells. Upon stimulation with Wnt, SIRT4 translocates from mitochondria to the cytoplasm and catalyzes Axin1 deacetylation, thus turning off the destruction complex. In this process, Lys147, a residue in the RGS domain of Axin1, plays a key role. We proved that the Axin1-K147R mutant impairs the assembly of β-TrCP to the destruction complex, which leads to β-catenin accumulation even without Wnt stimulation. In summary, our work proposes a new model for better understanding the initial stage of the canonical Wnt signaling pathway in which SIRT4 translocates from mitochondria into the cytoplasm to deacetylate Axin1-K147 after Wnt stimulation, which results in reduced assembly of β-TrCP to the destruction complex.

17 November 2023 in Cell Biology International
Verified
Journal Article
Closed access
SHShuo He
Shuo He
YLYan Liang
Yan Liang
YTYiyi Tan
Yiyi Tan
QLQing Liu
Qing Liu
TLTao Liu
Tao Liu
Shutao ZhengShutao Zheng
Shutao Zheng

18 June 2022 in Journal of Proteomics
Verified
Journal Article
Closed access
LYLifei Yang
Lifei Yang
ASAdili Salai
Adili Salai
XSXiaohong Sun
Xiaohong Sun
QLQing Liu
Qing Liu
TLTao Liu
Tao Liu
XLXiaomei LU
Xiaomei LU